Cargando…
Hematologic dysfunction in cancer: Mechanisms, effects on antitumor immunity, and roles in disease progression
With the major advances in cancer immunology and immunotherapy, it is critical to consider that most immune cells are short-lived and need to be continuously replenished from hematopoietic stem and progenitor cells. Hematologic abnormalities are prevalent in cancer patients, and many ground-breaking...
Autores principales: | Plackoska, Viktoria, Shaban, Dania, Nijnik, Anastasia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763314/ https://www.ncbi.nlm.nih.gov/pubmed/36561751 http://dx.doi.org/10.3389/fimmu.2022.1041010 |
Ejemplares similares
-
Editorial: Progress of programmed cell death in antitumor immunity
por: Yan, Fangfang, et al.
Publicado: (2023) -
Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation
por: Guo-Parke, Hong, et al.
Publicado: (2020) -
Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development
por: Liang, Yue, et al.
Publicado: (2023) -
Roles of CD4+ T cells as mediators of antitumor immunity
por: Kravtsov, Dmitriy S., et al.
Publicado: (2022) -
T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications
por: Chi, Xiaoxia, et al.
Publicado: (2023)